 | • レポートコード：QYR2104Z3296 • 出版社/出版日：QYResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、90ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療 |
| Single User | ￥553,800 (USD3,900) | ▷ お問い合わせ |
| Multi User/Five User | ￥830,700 (USD5,850) | ▷ お問い合わせ |
| Enterprise License（同一法人内共有可） | ￥1,107,600 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社発行の本調査資料では、IVDのグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（免疫診断、化学診断、分子診断、POCT、その他）、用途別市場規模（糖尿病、感染症、腫瘍/癌、心臓病、腎臓病、自己免疫疾患、薬物検査/薬理ゲノミクス、HIV/AIDS、その他）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。 ・市場概要 ・IVDの市場動向 ・企業の競争状況、市場シェア ・IVDの種類別市場規模（免疫診断、化学診断、分子診断、POCT、その他） ・IVDの用途別市場規模（糖尿病、感染症、腫瘍/癌、心臓病、腎臓病、自己免疫疾患、薬物検査/薬理ゲノミクス、HIV/AIDS、その他） ・IVDの北米市場規模2016-2027（アメリカ、カナダ） ・IVDのヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等） ・IVDのアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・IVDの中南米市場規模2016-2027（メキシコ、ブラジル） ・IVDの中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Roche Diagnostics、Danaher Corporation、Abbott Laboratories、Siemens、Sysmex、Thermo Fisher Scientific、Becton, Dickinson and Company、Biomérieux Sa、Bio-Rad Laboratories、Johnson & Johnson、Agilent Technologies、Qiagen、Diasorin、Ortho Clinical Diagnostics） ・結論 |
In vitro diagnostics are tests done on samples such as blood or tissue that have been taken from the human body. In vitro diagnostics can detect diseases or other conditions, and can be used to monitor a person’s overall health to help cure, treat, or prevent diseases.
In vitro diagnostics may also be used in precision medicine to identify patients who are likely to benefit from specific treatments or therapies. These in vitro diagnostics can include next generation sequencing tests, which scan a person’s DNA to detect genomic variations. Some tests are used in laboratory or other health professional settings and other tests are for consumers to use at home.
Market Analysis and Insights: Global IVD Market
The global IVD market size is projected to reach US$ 8464.6 million by 2026, from US$ 7026.5 million in 2019, at a CAGR of 2.7% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global IVD market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global IVD market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global IVD market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global IVD market.
Global IVD Scope and Market Size
IVD market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global IVD market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.
Segment by Type
Immuno Diagnostics
Chemistry Diagnostics
Molecular Diagnostics
POCT
Other
Segment by Application
Diabetes
Infectious Diseases
Oncology/Cancer
Cardiology
Nephrology
Autoimmune Diseases
Drug Testing/Pharmacogenomics
HIV/AIDS
Others
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
Roche Diagnostics
Danaher Corporation
Abbott Laboratories
Siemens
Sysmex
Thermo Fisher Scientific
Becton, Dickinson and Company
Biomérieux Sa
Bio-Rad Laboratories
Siemens
Sysmex
Qiagen
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global IVD Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Immuno Diagnostics
1.2.3 Chemistry Diagnostics
1.2.4 Molecular Diagnostics
1.2.5 POCT
1.2.6 Other
1.3 Market by Application
1.3.1 Global IVD Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Diabetes
1.3.3 Infectious Diseases
1.3.4 Oncology/Cancer
1.3.5 Cardiology
1.3.6 Nephrology
1.3.7 Autoimmune Diseases
1.3.8 Drug Testing/Pharmacogenomics
1.3.9 HIV/AIDS
1.3.10 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global IVD Market Perspective (2016-2027)
2.2 IVD Growth Trends by Regions
2.2.1 IVD Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 IVD Historic Market Share by Regions (2016-2021)
2.2.3 IVD Forecasted Market Size by Regions (2022-2027)
2.3 IVD Industry Dynamic
2.3.1 IVD Market Trends
2.3.2 IVD Market Drivers
2.3.3 IVD Market Challenges
2.3.4 IVD Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top IVD Players by Revenue
3.1.1 Global Top IVD Players by Revenue (2016-2021)
3.1.2 Global IVD Revenue Market Share by Players (2016-2021)
3.2 Global IVD Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by IVD Revenue
3.4 Global IVD Market Concentration Ratio
3.4.1 Global IVD Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by IVD Revenue in 2020
3.5 IVD Key Players Head office and Area Served
3.6 Key Players IVD Product Solution and Service
3.7 Date of Enter into IVD Market
3.8 Mergers & Acquisitions, Expansion Plans
4 IVD Breakdown Data by Type
4.1 Global IVD Historic Market Size by Type (2016-2021)
4.2 Global IVD Forecasted Market Size by Type (2022-2027)
5 IVD Breakdown Data by Application
5.1 Global IVD Historic Market Size by Application (2016-2021)
5.2 Global IVD Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America IVD Market Size (2016-2027)
6.2 North America IVD Market Size by Type
6.2.1 North America IVD Market Size by Type (2016-2021)
6.2.2 North America IVD Market Size by Type (2022-2027)
6.2.3 North America IVD Market Size by Type (2016-2027)
6.3 North America IVD Market Size by Application
6.3.1 North America IVD Market Size by Application (2016-2021)
6.3.2 North America IVD Market Size by Application (2022-2027)
6.3.3 North America IVD Market Size by Application (2016-2027)
6.4 North America IVD Market Size by Country
6.4.1 North America IVD Market Size by Country (2016-2021)
6.4.2 North America IVD Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada
7 Europe
7.1 Europe IVD Market Size (2016-2027)
7.2 Europe IVD Market Size by Type
7.2.1 Europe IVD Market Size by Type (2016-2021)
7.2.2 Europe IVD Market Size by Type (2022-2027)
7.2.3 Europe IVD Market Size by Type (2016-2027)
7.3 Europe IVD Market Size by Application
7.3.1 Europe IVD Market Size by Application (2016-2021)
7.3.2 Europe IVD Market Size by Application (2022-2027)
7.3.3 Europe IVD Market Size by Application (2016-2027)
7.4 Europe IVD Market Size by Country
7.4.1 Europe IVD Market Size by Country (2016-2021)
7.4.2 Europe IVD Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific IVD Market Size (2016-2027)
8.2 Asia-Pacific IVD Market Size by Type
8.2.1 Asia-Pacific IVD Market Size by Type (2016-2021)
8.2.2 Asia-Pacific IVD Market Size by Type (2022-2027)
8.2.3 Asia-Pacific IVD Market Size by Type (2016-2027)
8.3 Asia-Pacific IVD Market Size by Application
8.3.1 Asia-Pacific IVD Market Size by Application (2016-2021)
8.3.2 Asia-Pacific IVD Market Size by Application (2022-2027)
8.3.3 Asia-Pacific IVD Market Size by Application (2016-2027)
8.4 Asia-Pacific IVD Market Size by Region
8.4.1 Asia-Pacific IVD Market Size by Region (2016-2021)
8.4.2 Asia-Pacific IVD Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America IVD Market Size (2016-2027)
9.2 Latin America IVD Market Size by Type
9.2.1 Latin America IVD Market Size by Type (2016-2021)
9.2.2 Latin America IVD Market Size by Type (2022-2027)
9.2.3 Latin America IVD Market Size by Type (2016-2027)
9.3 Latin America IVD Market Size by Application
9.3.1 Latin America IVD Market Size by Application (2016-2021)
9.3.2 Latin America IVD Market Size by Application (2022-2027)
9.3.3 Latin America IVD Market Size by Application (2016-2027)
9.4 Latin America IVD Market Size by Country
9.4.1 Latin America IVD Market Size by Country (2016-2021)
9.4.2 Latin America IVD Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa IVD Market Size (2016-2027)
10.2 Middle East & Africa IVD Market Size by Type
10.2.1 Middle East & Africa IVD Market Size by Type (2016-2021)
10.2.2 Middle East & Africa IVD Market Size by Type (2022-2027)
10.2.3 Middle East & Africa IVD Market Size by Type (2016-2027)
10.3 Middle East & Africa IVD Market Size by Application
10.3.1 Middle East & Africa IVD Market Size by Application (2016-2021)
10.3.2 Middle East & Africa IVD Market Size by Application (2022-2027)
10.3.3 Middle East & Africa IVD Market Size by Application (2016-2027)
10.4 Middle East & Africa IVD Market Size by Country
10.4.1 Middle East & Africa IVD Market Size by Country (2016-2021)
10.4.2 Middle East & Africa IVD Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Roche Diagnostics
11.1.1 Roche Diagnostics Company Details
11.1.2 Roche Diagnostics Business Overview
11.1.3 Roche Diagnostics IVD Introduction
11.1.4 Roche Diagnostics Revenue in IVD Business (2016-2021)
11.1.5 Roche Diagnostics Recent Development
11.2 Danaher Corporation
11.2.1 Danaher Corporation Company Details
11.2.2 Danaher Corporation Business Overview
11.2.3 Danaher Corporation IVD Introduction
11.2.4 Danaher Corporation Revenue in IVD Business (2016-2021)
11.2.5 Danaher Corporation Recent Development
11.3 Abbott Laboratories
11.3.1 Abbott Laboratories Company Details
11.3.2 Abbott Laboratories Business Overview
11.3.3 Abbott Laboratories IVD Introduction
11.3.4 Abbott Laboratories Revenue in IVD Business (2016-2021)
11.3.5 Abbott Laboratories Recent Development
11.4 Siemens
11.4.1 Siemens Company Details
11.4.2 Siemens Business Overview
11.4.3 Siemens IVD Introduction
11.4.4 Siemens Revenue in IVD Business (2016-2021)
11.4.5 Siemens Recent Development
11.5 Sysmex
11.5.1 Sysmex Company Details
11.5.2 Sysmex Business Overview
11.5.3 Sysmex IVD Introduction
11.5.4 Sysmex Revenue in IVD Business (2016-2021)
11.5.5 Sysmex Recent Development
11.6 Thermo Fisher Scientific
11.6.1 Thermo Fisher Scientific Company Details
11.6.2 Thermo Fisher Scientific Business Overview
11.6.3 Thermo Fisher Scientific IVD Introduction
11.6.4 Thermo Fisher Scientific Revenue in IVD Business (2016-2021)
11.6.5 Thermo Fisher Scientific Recent Development
11.7 Becton, Dickinson and Company
11.7.1 Becton, Dickinson and Company Company Details
11.7.2 Becton, Dickinson and Company Business Overview
11.7.3 Becton, Dickinson and Company IVD Introduction
11.7.4 Becton, Dickinson and Company Revenue in IVD Business (2016-2021)
11.7.5 Becton, Dickinson and Company Recent Development
11.8 Biomérieux Sa
11.8.1 Biomérieux Sa Company Details
11.8.2 Biomérieux Sa Business Overview
11.8.3 Biomérieux Sa IVD Introduction
11.8.4 Biomérieux Sa Revenue in IVD Business (2016-2021)
11.8.5 Biomérieux Sa Recent Development
11.9 Bio-Rad Laboratories
11.9.1 Bio-Rad Laboratories Company Details
11.9.2 Bio-Rad Laboratories Business Overview
11.9.3 Bio-Rad Laboratories IVD Introduction
11.9.4 Bio-Rad Laboratories Revenue in IVD Business (2016-2021)
11.9.5 Bio-Rad Laboratories Recent Development
11.10 Johnson & Johnson
11.10.1 Johnson & Johnson Company Details
11.10.2 Johnson & Johnson Business Overview
11.10.3 Johnson & Johnson IVD Introduction
11.10.4 Johnson & Johnson Revenue in IVD Business (2016-2021)
11.10.5 Johnson & Johnson Recent Development
11.11 Agilent Technologies
11.11.1 Agilent Technologies Company Details
11.11.2 Agilent Technologies Business Overview
11.11.3 Agilent Technologies IVD Introduction
11.11.4 Agilent Technologies Revenue in IVD Business (2016-2021)
11.11.5 Agilent Technologies Recent Development
11.12 Qiagen
11.12.1 Qiagen Company Details
11.12.2 Qiagen Business Overview
11.12.3 Qiagen IVD Introduction
11.12.4 Qiagen Revenue in IVD Business (2016-2021)
11.12.5 Qiagen Recent Development
11.13 Diasorin
11.13.1 Diasorin Company Details
11.13.2 Diasorin Business Overview
11.13.3 Diasorin IVD Introduction
11.13.4 Diasorin Revenue in IVD Business (2016-2021)
11.13.5 Diasorin Recent Development
11.14 Ortho Clinical Diagnostics
11.14.1 Ortho Clinical Diagnostics Company Details
11.14.2 Ortho Clinical Diagnostics Business Overview
11.14.3 Ortho Clinical Diagnostics IVD Introduction
11.14.4 Ortho Clinical Diagnostics Revenue in IVD Business (2016-2021)
11.14.5 Ortho Clinical Diagnostics Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Table 1. Global IVD Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Immuno Diagnostics
Table 3. Key Players of Chemistry Diagnostics
Table 4. Key Players of Molecular Diagnostics
Table 5. Key Players of POCT
Table 6. Key Players of Other
Table 7. Global IVD Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 8. Global IVD Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 9. Global IVD Market Size by Regions (2016-2021) & (US$ Million)
Table 10. Global IVD Market Share by Regions (2016-2021)
Table 11. Global IVD Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 12. Global IVD Market Share by Regions (2022-2027)
Table 13. IVD Market Trends
Table 14. IVD Market Drivers
Table 15. IVD Market Challenges
Table 16. IVD Market Restraints
Table 17. Global IVD Revenue by Players (2016-2021) & (US$ Million)
Table 18. Global IVD Market Share by Players (2016-2021)
Table 19. Global Top IVD Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in IVD as of 2020)
Table 20. Ranking of Global Top IVD Companies by Revenue (US$ Million) in 2020
Table 21. Global 5 Largest Players Market Share by IVD Revenue (CR5 and HHI) & (2016-2021)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players IVD Product Solution and Service
Table 24. Date of Enter into IVD Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global IVD Market Size by Type (2016-2021) (US$ Million)
Table 27. Global IVD Revenue Market Share by Type (2016-2021)
Table 28. Global IVD Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 29. Global IVD Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 30. Global IVD Market Size Share by Application (2016-2021) & (US$ Million)
Table 31. Global IVD Revenue Market Share by Application (2016-2021)
Table 32. Global IVD Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 33. Global IVD Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 34. North America IVD Market Size by Type (2016-2021) (US$ Million)
Table 35. North America IVD Market Size by Type (2022-2027) & (US$ Million)
Table 36. North America IVD Market Size by Application (2016-2021) (US$ Million)
Table 37. North America IVD Market Size by Application (2022-2027) & (US$ Million)
Table 38. North America IVD Market Size by Country (2016-2021) & (US$ Million)
Table 39. North America IVD Market Size by Country (2022-2027) & (US$ Million)
Table 40. Europe IVD Market Size by Type (2016-2021) (US$ Million)
Table 41. Europe IVD Market Size by Type (2022-2027) & (US$ Million)
Table 42. Europe IVD Market Size by Application (2016-2021) (US$ Million)
Table 43. Europe IVD Market Size by Application (2022-2027) & (US$ Million)
Table 44. Europe IVD Market Size by Country (2016-2021) & (US$ Million)
Table 45. Europe IVD Market Size by Country (2022-2027) & (US$ Million)
Table 46. Asia-Pacific IVD Market Size by Type (2016-2021) (US$ Million)
Table 47. Asia-Pacific IVD Market Size by Type (2022-2027) & (US$ Million)
Table 48. Asia-Pacific IVD Market Size by Application (2016-2021) (US$ Million)
Table 49. Asia-Pacific IVD Market Size by Application (2022-2027) & (US$ Million)
Table 50. Asia-Pacific IVD Market Size by Region (2016-2021) & (US$ Million)
Table 51. Asia-Pacific IVD Market Size by Region (2022-2027) & (US$ Million)
Table 52. Latin America IVD Market Size by Type (2016-2021) (US$ Million)
Table 53. Latin America IVD Market Size by Type (2022-2027) & (US$ Million)
Table 54. Latin America IVD Market Size by Application (2016-2021) (US$ Million)
Table 55. Latin America IVD Market Size by Application (2022-2027) & (US$ Million)
Table 56. Latin America IVD Market Size by Country (2016-2021) & (US$ Million)
Table 57. Latin America IVD Market Size by Country (2022-2027) & (US$ Million)
Table 58. Middle East & Africa IVD Market Size by Type (2016-2021) (US$ Million)
Table 59. Middle East & Africa IVD Market Size by Type (2022-2027) & (US$ Million)
Table 60. Middle East & Africa IVD Market Size by Application (2016-2021) (US$ Million)
Table 61. Middle East & Africa IVD Market Size by Application (2022-2027) & (US$ Million)
Table 62. Middle East & Africa IVD Market Size by Country (2016-2021) & (US$ Million)
Table 63. Middle East & Africa IVD Market Size by Country (2022-2027) & (US$ Million)
Table 64. Roche Diagnostics Company Details
Table 65. Roche Diagnostics Business Overview
Table 66. Roche Diagnostics IVD Product
Table 67. Roche Diagnostics Revenue in IVD Business (2016-2021) & (US$ Million)
Table 68. Roche Diagnostics Recent Development
Table 69. Danaher Corporation Company Details
Table 70. Danaher Corporation Business Overview
Table 71. Danaher Corporation IVD Product
Table 72. Danaher Corporation Revenue in IVD Business (2016-2021) & (US$ Million)
Table 73. Danaher Corporation Recent Development
Table 74. Abbott Laboratories Company Details
Table 75. Abbott Laboratories Business Overview
Table 76. Abbott Laboratories IVD Product
Table 77. Abbott Laboratories Revenue in IVD Business (2016-2021) & (US$ Million)
Table 78. Abbott Laboratories Recent Development
Table 79. Siemens Company Details
Table 80. Siemens Business Overview
Table 81. Siemens IVD Product
Table 82. Siemens Revenue in IVD Business (2016-2021) & (US$ Million)
Table 83. Siemens Recent Development
Table 84. Sysmex Company Details
Table 85. Sysmex Business Overview
Table 86. Sysmex IVD Product
Table 87. Sysmex Revenue in IVD Business (2016-2021) & (US$ Million)
Table 88. Sysmex Recent Development
Table 89. Thermo Fisher Scientific Company Details
Table 90. Thermo Fisher Scientific Business Overview
Table 91. Thermo Fisher Scientific IVD Product
Table 92. Thermo Fisher Scientific Revenue in IVD Business (2016-2021) & (US$ Million)
Table 93. Thermo Fisher Scientific Recent Development
Table 94. Becton, Dickinson and Company Company Details
Table 95. Becton, Dickinson and Company Business Overview
Table 96. Becton, Dickinson and Company IVD Product
Table 97. Becton, Dickinson and Company Revenue in IVD Business (2016-2021) & (US$ Million)
Table 98. Becton, Dickinson and Company Recent Development
Table 99. Biomérieux Sa Company Details
Table 100. Biomérieux Sa Business Overview
Table 101. Biomérieux Sa Revenue in IVD Business (2016-2021) & (US$ Million)
Table 102. Biomérieux Sa Recent Development
Table 103. Bio-Rad Laboratories Company Details
Table 104. Bio-Rad Laboratories Business Overview
Table 105. Bio-Rad Laboratories IVD Product
Table 106. Bio-Rad Laboratories Revenue in IVD Business (2016-2021) & (US$ Million)
Table 107. Bio-Rad Laboratories Recent Development
Table 108. Johnson & Johnson Company Details
Table 109. Johnson & Johnson Business Overview
Table 110. Johnson & Johnson IVD Product
Table 111. Johnson & Johnson Revenue in IVD Business (2016-2021) & (US$ Million)
Table 112. Johnson & Johnson Recent Development
Table 113. Agilent Technologies Company Details
Table 114. Agilent Technologies Business Overview
Table 115. Agilent Technologies IVD Product
Table 116. Agilent Technologies Revenue in IVD Business (2016-2021) & (US$ Million)
Table 117. Agilent Technologies Recent Development
Table 118. Qiagen Company Details
Table 119. Qiagen Business Overview
Table 120. Qiagen IVD Product
Table 121. Qiagen Revenue in IVD Business (2016-2021) & (US$ Million)
Table 122. Qiagen Recent Development
Table 123. Diasorin Company Details
Table 124. Diasorin Business Overview
Table 125. Diasorin IVD Product
Table 126. Diasorin Revenue in IVD Business (2016-2021) & (US$ Million)
Table 127. Diasorin Recent Development
Table 128. Ortho Clinical Diagnostics Company Details
Table 129. Ortho Clinical Diagnostics Business Overview
Table 130. Ortho Clinical Diagnostics IVD Product
Table 131. Ortho Clinical Diagnostics Revenue in IVD Business (2016-2021) & (US$ Million)
Table 132. Ortho Clinical Diagnostics Recent Development
Table 133. Research Programs/Design for This Report
Table 134. Key Data Information from Secondary Sources
Table 135. Key Data Information from Primary Sources
List of Figures
Figure 1. Global IVD Market Share by Type: 2020 VS 2027
Figure 2. Immuno Diagnostics Features
Figure 3. Chemistry Diagnostics Features
Figure 4. Molecular Diagnostics Features
Figure 5. POCT Features
Figure 6. Other Features
Figure 7. Global IVD Market Share by Application: 2020 VS 2027
Figure 8. Diabetes Case Studies
Figure 9. Infectious Diseases Case Studies
Figure 10. Oncology/Cancer Case Studies
Figure 11. Cardiology Case Studies
Figure 12. Nephrology Case Studies
Figure 13. Autoimmune Diseases Case Studies
Figure 14. Drug Testing/Pharmacogenomics Case Studies
Figure 15. HIV/AIDS Case Studies
Figure 16. Others Case Studies
Figure 17. IVD Report Years Considered
Figure 18. Global IVD Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 19. Global IVD Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 20. Global IVD Market Share by Regions: 2020 VS 2027
Figure 21. Global IVD Market Share by Regions (2022-2027)
Figure 22. Global IVD Market Share by Players in 2020
Figure 23. Global Top IVD Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in IVD as of 2020
Figure 24. The Top 10 and 5 Players Market Share by IVD Revenue in 2020
Figure 25. Global IVD Revenue Market Share by Type (2016-2021)
Figure 26. Global IVD Revenue Market Share by Type (2022-2027)
Figure 27. North America IVD Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 28. North America IVD Market Share by Type (2016-2027)
Figure 29. North America IVD Market Share by Application (2016-2027)
Figure 30. North America IVD Market Share by Country (2016-2027)
Figure 31. United States IVD Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Canada IVD Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Europe IVD Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Europe IVD Market Share by Type (2016-2027)
Figure 35. Europe IVD Market Share by Application (2016-2027)
Figure 36. Europe IVD Market Share by Country (2016-2027)
Figure 37. Germany IVD Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. France IVD Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. U.K. IVD Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. Italy IVD Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Russia IVD Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Nordic IVD Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Asia-Pacific IVD Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Asia-Pacific IVD Market Share by Type (2016-2027)
Figure 45. Asia-Pacific IVD Market Share by Application (2016-2027)
Figure 46. Asia-Pacific IVD Market Share by Region (2016-2027)
Figure 47. China IVD Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. Japan IVD Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. South Korea IVD Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Southeast Asia IVD Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. India IVD Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Australia IVD Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Latin America IVD Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 54. Latin America IVD Market Share by Type (2016-2027)
Figure 55. Latin America IVD Market Share by Application (2016-2027)
Figure 56. Latin America IVD Market Share by Country (2016-2027)
Figure 57. Mexico IVD Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. Brazil IVD Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. Middle East & Africa IVD Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 60. Middle East & Africa IVD Market Share by Type (2016-2027)
Figure 61. Middle East & Africa IVD Market Share by Application (2016-2027)
Figure 62. Middle East & Africa IVD Market Share by Country (2016-2027)
Figure 63. Turkey IVD Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 64. Saudi Arabia IVD Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 65. UAE IVD Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 66. Roche Diagnostics Revenue Growth Rate in IVD Business (2016-2021)
Figure 67. Danaher Corporation Revenue Growth Rate in IVD Business (2016-2021)
Figure 68. Abbott Laboratories Revenue Growth Rate in IVD Business (2016-2021)
Figure 69. Siemens Revenue Growth Rate in IVD Business (2016-2021)
Figure 70. Sysmex Revenue Growth Rate in IVD Business (2016-2021)
Figure 71. Thermo Fisher Scientific Revenue Growth Rate in IVD Business (2016-2021)
Figure 72. Becton, Dickinson and Company Revenue Growth Rate in IVD Business (2016-2021)
Figure 73. Biomérieux Sa Revenue Growth Rate in IVD Business (2016-2021)
Figure 74. Bio-Rad Laboratories Revenue Growth Rate in IVD Business (2016-2021)
Figure 75. Johnson & Johnson Revenue Growth Rate in IVD Business (2016-2021)
Figure 76. Agilent Technologies Revenue Growth Rate in IVD Business (2016-2021)
Figure 77. Qiagen Revenue Growth Rate in IVD Business (2016-2021)
Figure 78. Diasorin Revenue Growth Rate in IVD Business (2016-2021)
Figure 79. Ortho Clinical Diagnostics Revenue Growth Rate in IVD Business (2016-2021)
Figure 80. Bottom-up and Top-down Approaches for This Report
Figure 81. Data Triangulation
Figure 82. Key Executives Interviewed
世界の自己免疫疾患用体外診断用医薬品（IVD）・薬事未承認検査市場規模・現状・予測（2021年-2027年） In vitro diagnostics (IVD) are tests on bodily samples like blood, tissue or urine. IVDs are used to detect diseases, conditions, or infections.LDT for autoimmune diseases are tests specially developed in laboratory testing some autoimmune diseases. The market growth is attributed to rising occurren…- 世界の感染症検査における分子診断市場規模・現状・予測（2021年-2027年） Molecular diagnostics is a technique used to detect the presence of and identify genetic materials and proteins associated with specific health conditions and diseases, and infectious agents in body fluids such as blood, urine, or sputum. Molecular diagnostics for infectious disease testing is used …
- 世界の感染症診断市場規模・現状・予測（2021年-2027年） Infectious-disease diagnostics is the procedure by which the causative agent of an infectious disease is identified and often characterized. Market Analysis and Insights: Global Infectious Disease Diagnostics Market The global Infectious Disease Diagnostics market size is projected to reach US$ 1687…
- 世界のDNAプローブベース診断市場規模・現状・予測（2021年-2027年） DNA probes are stretches of single-stranded DNA, utilized to identify the presence of complementary nucleic acid sequences (target sequences) by hybridization. Marked with a label like color or fluorescence, they allow researchers to detect a distinct sequence of DNA in a mixture. Firstly, the DNA s…
- 世界の膀胱がん治療・診断市場規模・現状・予測（2021年-2027年） The bladder is an organ located in the lower abdominal region near the pelvic bones and acts as a reservoir of urine. A bladder cancer is characterized by the abnormal cell growth in the bladder, which impairs the proper functioning of urinary system. Majority of bladder cancer develops in the inner…